Breaking News

WuXi PharmaTech Invests in TruTag Technologies

April 8, 2014

To explore collaborations for on-dose authentication solution

WuXi PharmaTech (Cayman) Inc. has made an investment in TruTag Technologies, Inc., a developer of the edible, covert security platform designed to address product counterfeiting. WuXi and TruTag will also explore collaborations to offer WuXi’s customers the TruTag on-dose authentication solution to help prevent counterfeiting and enhance drug safety.
 
TruTag microtags (TruTags) are inert and edible and can be integrated into a product without packaging or labels. According to the company, the technology has millions of optical patterns that can be embedded into a TruTag, a dust-sized particle smaller than the width of a human hair. This technology allows pharmaceutical companies to be able to field-read finished tablets circulating in the wholesale and retail market to determine the authenticity and origin of medicines, including site and date of manufacture, lots, and other critical data.
 
"TruTag is very excited to work with WuXi to explore the development of our on-dose authentication solution for WuXi’s pharmaceutical customers,” said Dr. Hank C.K. Wuh, chairman of TruTag Technologies. “This innovative technology is an important new weapon in fighting the growing global problem of counterfeit drugs.”
 
"WuXi is pleased to invest in this cutting-edge technology and to explore its further development to enhance patient safety and protect our customers’ intellectual property,” said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. 
 

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016